UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a) of the Securities
Exchange
Act of 1934 (Amendment No. )
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐ |
Preliminary
Proxy Statement |
☐ |
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ |
Definitive
Proxy Statement |
☐ |
Definitive
Additional Materials |
☐ |
Soliciting
Material Pursuant to §240.14a-12 |
Research
Frontiers Incorporated
(Name
of Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
☒ |
No
fee required. |
|
|
☐ |
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
1) |
Title
of each class of securities to which transaction applies: |
|
|
|
|
2) |
Aggregate
number of securities to which transaction applies: |
|
|
|
|
3) |
Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined): |
|
|
|
|
4) |
Proposed
maximum aggregate value of transaction: |
|
|
|
|
5) |
Total
fee paid: |
☐ |
Fee
paid previously with preliminary materials. |
|
|
☐ |
Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its
filing. |
|
1) |
Amount
Previously Paid: |
|
|
|
|
|
|
|
2) |
Form,
Schedule or Registration Statement No.: |
|
|
|
|
|
|
|
3) |
Filing
Party: |
|
|
|
|
|
|
|
4) |
Date
Filed: |
|
|
|
240
Crossways Park Drive
Woodbury,
NY 11797
(516)
364-1902
NOTICE
OF ANNUAL MEETING OF STOCKHOLDERS
June
8, 2023 at 11:00 A.M.
To
the Stockholders of Research Frontiers Incorporated:
Notice
is hereby given that the Annual Meeting of Stockholders of Research Frontiers Incorporated (the “Company”) will be held at
the Company’s corporate office located at 240 Crossways Park Drive, Woodbury, New York 11797, on June 8, 2023 at 11:00 A.M., local
time, for the following purposes:
|
1. |
To
elect one Class III director; |
|
|
|
|
2. |
To
ratify the selection of CohnReznick LLP as the independent registered public accountants of the Company for the fiscal year ending
December 31, 2023; |
|
|
|
|
3. |
To
vote on an advisory resolution on the Company’s executive compensation; |
|
|
|
|
4. |
To
vote on the frequency of future stockholder advisory votes on the Company’s executive compensation; and |
|
|
|
|
5. |
To
transact such other business as may properly come before the meeting or any adjournments thereof. |
The
Board of Directors has fixed the close of business on April 18, 2023 as the record date for the determination of stockholders entitled
to notice of, and to vote at, the meeting or any adjournments thereof.
The
Board of Directors requests all stockholders to sign and date the enclosed form of proxy and return it in the postage paid, self-addressed
envelope provided for your convenience. Please do this whether or not you plan to attend the meeting. Should you attend, you may, if
you wish, withdraw your proxy and vote your shares in person. BECAUSE YOUR BROKER MAY NOT HAVE DISCRETION TO VOTE ON ALL OF THE ABOVE
MATTERS, IT IS IMPORTANT THAT YOU SEND IN YOUR PROXY.
|
By
Order of the Board of Directors, |
|
|
|
|
|
JOSEPH
M. HARARY , Secretary |
Woodbury,
New York
April
28, 2023
RESEARCH
FRONTIERS INCORPORATED
240
CROSSWAYS PARK DRIVE, WOODBURY, NY 11797 (516) 364-1902
PROXY
STATEMENT
ANNUAL
MEETING OF STOCKHOLDERS
To
be held on Thursday, June 8, 2023
This
Proxy Statement is furnished by the Board of Directors of Research Frontiers Incorporated (the “Company”) in connection with
the solicitation by the Company of proxies to be voted at the Annual Meeting of Stockholders which will be held at the Company’s
corporate offices located at 240 Crossways Park Drive, Woodbury, New York 11797, on June 8, 2023 at 11:00 A.M., local time, and all adjournments
thereof.
We
currently intend to hold our annual meeting in person. However, we are actively monitoring the coronavirus (COVID-19) situation and we
are sensitive to the public health and travel concerns our shareholders may have and the protocols that federal, state, and local governments
may impose. In the event it is not possible or advisable to hold our annual meeting in person, we will announce alternative arrangements
for the meeting as promptly as practicable, which may include holding the meeting solely by means of remote communication. Please monitor
our annual meeting website at https://www.cstproxy.com/smartglass/2023/ for updated information. If you are planning to attend
our meeting, please check the website one week prior to the meeting date. As always, we encourage you to vote your shares prior to the
annual meeting.
Any
stockholder giving a proxy will have the right to revoke it at any time prior to the time it is voted. A proxy may be revoked by written
notice to the Company, Attention: Secretary, by execution of a subsequent proxy or by attendance and voting in person at the Annual Meeting
of Stockholders. Attendance at the meeting will not automatically revoke the proxy. All shares represented by effective proxies will
be voted at the Annual Meeting of Stockholders, or at any adjournment thereof. Unless otherwise specified in the proxy, shares represented
by proxies will be voted (i) for the election of the nominee for director recommended by the Board of Directors listed below; (ii) for
the ratification of the selection of the independent registered public accountants; (iii) for the approval, by non-binding vote, of the
Company’s executive compensation and (iv) for the approval, by non-binding vote, of three years as the frequency of stockholder
advisory votes on the Company’s executive compensation. The cost of proxy solicitations will be borne by the Company. In addition
to solicitations of proxies by use of the mails, some officers or employees of the Company, without additional remuneration, may solicit
proxies personally or by telephone. The Company will also request brokers, dealers, banks and their nominees to solicit proxies from
their clients, where appropriate, and will reimburse them for reasonable expenses related thereto.
The
Company’s executive offices are located at 240 Crossways Park Drive, Woodbury, New York 11797. The Company believes that it can
learn from constructive dialog with stockholders and other stakeholders and therefore actively encourages communications with all such
interested parties. All appropriate e-mail communications to Directors@SmartGlass.com will be forwarded to each director of the Company.
Furthermore, subject to the limits imposed by U.S. Securities and Exchange Commission (“SEC”) regulations regarding disclosure
of information that is not made generally available to all stockholders at the same time, we will endeavor to respond to specific questions
or suggestions which, in the opinion of management or the Board, merit individual response. On or about May 1, 2023 this Proxy Statement
and the accompanying form of proxy, together with a copy of the Annual Report of the Company for the year ended December 31, 2022,
including financial statements, are to be mailed to each stockholder of record at the close of business on April 18, 2023.
IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 8, 2023.
This
Proxy Statement is available at www.smartglass.com/proxy.asp.
VOTING
SECURITIES AND SECURITY OWNERSHIP
Shares
Entitled to Vote, Quorum and Required Vote
Only
stockholders of record at the close of business on April 18, 2023 are entitled to vote at the meeting. As of April 18, 2023, the Company
had issued and outstanding and entitled to vote 33,509,287 shares of common stock, par value $0.0001 per share (the “Common Stock”),
the Company’s only class of voting securities outstanding. Each share of Common Stock entitles the holder thereof to one vote.
As
a stockholder of record, you may vote in person at the Annual Meeting or you may vote by proxy without attending the meeting. If you
are a registered stockholder, you may vote your shares by giving a proxy via mail, telephone or internet. To vote your proxy by mail,
indicate your voting choices, sign and date your proxy card and return it in the postage-paid envelope provided. You may vote by telephone
or internet by following the instructions on your proxy card. If you hold your shares through a broker, bank or other nominee, that institution
will send you separate instructions describing the procedure for voting your shares.
If
you provide a properly executed proxy before voting at the Annual Meeting is closed, the persons listed on the proxy card will vote your
shares of Common Stock in accordance with your directions. If you do not indicate how your shares are to be voted, the persons listed
on the proxy card will vote your shares as recommended by the Board of Directors. The persons listed on the proxy card will also have
the discretionary authority to vote on your behalf on any other matter that is properly brought before the Annual Meeting. If you wish
to give a proxy to someone other than the persons listed on the proxy card, please cross out the names of the people listed on the proxy
card and add the name of the person holding your proxy.
If
we receive a valid proxy before voting at the Annual Meeting is closed, your shares are voted as indicated on the proxy card. If you
indicate on your proxy card that you wish to “abstain” or “withhold,” as the case may be, from voting on an item,
your shares will not be voted on that item.
If
you do not provide voting instructions to your broker or nominee at least ten days before the Annual Meeting, that person has discretion
to vote your shares on matters that the Nasdaq Capital Market has determined are routine. However, a broker or nominee cannot vote shares
on non-routine matters without your instructions, and this is referred to as a “broker non-vote.”
Even
though your broker may have discretionary authority under current Nasdaq Capital Market rules to vote your shares on your behalf on the
proposal regarding the ratification of CohnReznick LLP as the independent registered public accountants of the Company for 2023, your
broker does not have authority to vote on the election of directors, so it is important that you vote your shares and send in your proxy.
We
cannot conduct business at the Annual Meeting unless a quorum is present. In order to have a quorum, a majority of the shares of the
Common Stock that are outstanding and entitled to vote at the meeting must be represented in person or by proxy. Abstentions and broker
non-votes will be counted to determine whether there is a quorum present. If a quorum is not present, the Annual Meeting will be rescheduled
for a later date.
A
Director is elected by a plurality of the votes cast at the meeting and the nominee for the Class III director who receives the most
votes will be elected. Please note that brokerage firms or other nominees may not vote your shares with respect to matters that are not
“routine” under the rules. The rules were amended to provide that the election of directors is no longer a “routine”
matter. Brokerage firms or other nominees may not vote your shares with respect to the election of directors without specific instructions
from you as to how your shares are to be voted. Broker non-votes will have no effect on the outcome of the vote.
The
ratification and appointment of our independent registered public accounting firm for 2023 requires an affirmative majority of the total
votes cast “FOR” and “AGAINST” to be approved. This matter is considered a “routine” under the rules
and, therefore, brokerage firms and other nominees have the authority under the rules to vote your unvoted shares with respect to this
matter if you have not furnished voting instructions within a specified period prior to the meeting. Abstentions will have the same effect
as votes against the proposal. Broker non-votes will have no effect on the outcome of the vote.
Security
Ownership of Principal Stockholders and Management
The
following table sets forth certain information with respect to those persons or groups known to the Company who beneficially own more
than 5% of the Common Stock and for all directors and executive officers of the Company individually and as a group.
| |
Amount
and | | |
| | |
| |
| |
Nature
of | | |
Exercisable | | |
| |
| |
Beneficial | | |
Warrants | | |
Percent | |
Name
of Beneficial Owner | |
Ownership
(1) | | |
and
Options | | |
of
Class | |
Five
Percent Stockholders: | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | |
Gauzy
Ltd. | |
| 1,838,824 | | |
| - | | |
| 5.5 | |
14
Hathiya Street | |
| | | |
| | | |
| | |
Tel-Aviv
Yafo Israel 6816914 | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | |
Directors
and Executive Officers: | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | |
Joseph
M. Harary | |
| 847,650
| (2) | |
| 349,100 | | |
| 2.5 | |
Darryl
Daigle | |
| 712,238 | (3) | |
| 286,293 | | |
| 2.1 | |
Alexander
Kaganowicz | |
| 468,421 | (4) | |
| 286,293 | | |
| 1.4 | |
Michael
R. LaPointe | |
| 95,884 | (5) | |
| 51,850 | | |
| 0.3 | |
| |
| | | |
| | | |
| | |
All
directors and officers as a group (4 persons) | |
| 2,124,193 | (6) | |
| 973,536 | | |
| 6.16 | |
|
(1) |
All
information is as of April 18, 2023 and was determined in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), based upon information furnished by the persons listed or contained in filings made by
them with the SEC or otherwise known to the Company. Unless otherwise indicated, beneficial ownership disclosed consists of sole
voting and dispositive power, and also includes options and warrants held by the listed persons that are presently exercisable or
exercisable within the next 60 days, and awards of restricted stock subject to vesting are assumed to be fully issued and outstanding.
Shares of Common Stock of the Company acquired by officers, directors and employees through the exercise of stock options or otherwise
are subject to restrictions on their transfer, including restrictions imposed by applicable securities laws, as well as additional
restrictions imposed by the Company in accordance with written agreements and policy statements. The mailing address for the above
individuals is c/o Research Frontiers Incorporated, 240 Crossways Park Drive, Woodbury, NY 11797. |
|
|
|
|
(2) |
All
of Mr. Harary’s shares of Common Stock are pledged to a third party as collateral security for certain obligations. |
|
|
|
|
(3) |
Includes:
(i) 69,808 shares of Common Stock held by Mr. Daigle’s business of which he has a 50% ownership interest, (ii) 125,000 shares
of Common Stock owned by Mr. Daigle’s wife, as to which shares Mr. Daigle disclaims beneficial ownership, (iii) 25,226 shares
of Common Stock held in an IRA by Mr. Daigle’s wife, and (iv) 2,769 shares of Common Stock held as a custodian for Mr. Daigle’s
grandchildren. |
|
|
|
|
(4) |
Includes
19,205 shares of Common Stock held in an IRA by reporting person’s wife. |
|
|
|
|
(5) |
Includes
898 shares of Common Stock owned by Mr. LaPointe’s wife, as to which shares Mr. LaPointe disclaims beneficial ownership. |
|
|
|
|
(6) |
Includes
the securities described above in footnotes (2) through (5). |
ELECTION
OF DIRECTORS
(Item
1)
One
director of the Company will be elected at the 2023 Annual Meeting of Stockholders.
The
Board of Directors recommends a vote FOR Darryl Daigle as a Class III director, and it is intended that proxies not marked to the contrary
will be so voted.
Background
The
Board of Directors is divided into three classes, Class I, Class II and Class III, which is intended to be as nearly equal in number
as possible. Each class typically serves three years, with the terms of office of the respective classes expiring in successive years.
The Company currently has three directors with two of these directors being independent directors. One of these
individuals is a Class I director, one of these individuals is a Class II director, and one of these individuals is a Class III
director.
DIRECTOR
RECOMMENDED BY THE BOARD OF DIRECTORS
The
Board of Directors, upon recommendation of the Nominating and Corporate Governance Committee, proposes that Darryl Daigle be elected
to serve as a Class III director and hold office for a three-year term expiring at the 2026 Annual Meeting of Stockholders, and until
the election and qualification of a respective successor. Mr. Daigle (the “Board Nominee”) has indicated a willingness to
serve as a director. If no other choice is specified in the accompanying proxy, the person named therein as proxies have advised the
Board of Directors that it is their present intention to vote the proxy for the election of the Board Nominee. Each of the current members
of the Board of Directors of the Company was elected to such office by the stockholders of the Company. Should a Board Nominee become
unable to accept nomination or election, it is intended that the person named in the accompanying proxy will vote for the election of
such other person as the Board of Directors may nominate in the place of such Board Nominee on the recommendation of the Nominating and
Corporate Governance Committee. There is no indication at present that the Board Nominee will be unable to accept nomination.
We
believe that the members of our Board of Directors represent a desirable mix of backgrounds, skills and experience. The following biographical
information is provided with respect to each Board Nominee, including the specific experience, qualifications, attributes or skills that
led to the conclusion that each Board Nominee should serve as one of our directors considering our business and structure.
Director
Nominee Standing for Election
Class
III - Term Expires at the 2023 Annual Meeting of Stockholders
Darryl
Daigle
Darryl
Daigle, age 65, has been a shareholder of Research Frontiers since 1991 and has been a director of the Company since June 2012. Mr. Daigle
is the Chairman of the Company’s Audit Committee and Compensation Committee, and is a member of the Stock
Option and Nominating and Corporate Governance Committees. Mr. Daigle has been a principal owner of several profitable family-owned businesses
in Louisiana. One of these, SPD Equipment Sales Inc., sells oilfield and marine equipment to the marine and oil and gas industries. Another
business, S&D Bait Company LLC serves the commercial and recreational fishing industries in Louisiana. Mr. Daigle earned a business
degree from Texas Tech University and is a former member of the Louisiana Seafood Promotion Board, to which he was appointed by Governor
Murphy J. Foster, Jr.
INFORMATION
ABOUT DIRECTORS CONTINUING IN OFFICE
The
following directors will be continuing in office for the term indicated and are not up for re-election at the 2023 Annual Meeting of
Stockholders:
Class
I - Term Expires at the 2024 Annual Meeting of Stockholders
Joseph
M. Harary
Joe
Harary, age 62, became Vice President and General Counsel to the Company in April 1992 and has been a director of the Company since February
1993. In December 1999, Mr. Harary was promoted to the position of Executive Vice President and General Counsel, and in February 2002
was promoted to the position of President and Chief Operating Officer of the Company. Mr. Harary was promoted to his present position
of President and Chief Executive Officer of the Company in January 2009. Mr. Harary has also been the Treasurer and Chief Financial Officer
of the Company from 2005 to 2010, and its corporate Secretary since 2007. Prior to joining the Company, Mr. Harary’s corporate
law practice emphasized technology, licensing, mergers and acquisitions, securities law, and intellectual property law at three prestigious
New York City law firms. Mr. Harary graduated Summa Cum Laude from Columbia College in 1983 with an A.B. degree in economics and received
a Juris Doctor degree from Columbia Law School in 1986 where he was a Harlan Fiske Stone Scholar. Prior to attending law school, Mr.
Harary was an economist with the Federal Reserve Bank of New York. Mr. Harary’s significant and diverse managerial experience with
the Company for more than 30 years, including executive and operational roles, gives him unique insights into the Company’s business,
relationships, challenges, opportunities and operations.
Class
II - Term Expires at the 2025 Annual Meeting of Stockholders
Alexander
Kaganowicz
Alexander
Kaganowicz, age 76, has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr.
Kaganowicz is the Chairman of the Company’s Nominating and Corporate Governance Committee and is a member of the Audit and Compensation
and Stock Option Committees. In addition to being a shareholder, Dr. Kaganowicz has been involved in the performance and market testing
of SPD products, including several demonstration installations of SPD SmartGlass in his home and work locations. For the past 31 years
Dr. Kaganowicz has been the proprietor of a successful automotive services business in Freeport, NY. He holds a Doctorate in Chemistry
from the University of Rome, has served as Adjunct Associate Professor at the New York Institute of Technology, and has worked as a clinical
chemist with titles of Director of the Chemistry Department and Manager of the Pathology Department at the Booth Memorial Medical Center
in Queens, NY (from 1974 to 1989). In addition, he owned and operated several successful medical supply companies in New York and Pennsylvania
from 1989 to 2005. Dr. Kaganowicz research experience has resulted in several publications and textbook contributions.
CORPORATE
GOVERNANCE
Board
Leadership Structure and Risk Oversight
The
Company promoted the Company’s President, Joseph M. Harary, to his current position as Chief Executive Officer effective in January
2009. Since 2009, the Company had separated the positions of Chairman and Chief Executive Officer. The Company’s founder, Robert
L. Saxe served as the Company’s Chairman since the Company’s formation until his death in 2016. A new Chairman has not been
appointed since the Company believes that the separation of responsibilities between the Chairman and Chief Executive is not necessary
given the size of the Company’s Board of Directors and its composition, level of involvement, composition by long-term shareholders
of the Company, and diversity. In addition, since the Board is responsible for the monitoring of the performance of the Company and of
its Chief Executive Officer, together with the fact that the majority of the Board members are independent under the applicable listing
standards of the NASDAQ Capital Market, helps to ensure that management functions are properly executed. The committees of the Board
are each chaired by an independent director. Mr. Alexander Kaganowicz chairs the Nominating and Corporate Governance Committee, and Mr.
Darryl Daigle chairs the Audit Committee and the Compensation Committee. Board Committee chairs are typically reviewed and determined
annually after the Corporation’s Annual Meeting of Stockholders.
Our
Board oversees a Company-wide approach to risk management that is designed to support the achievement of organizational objectives, including
strategic objectives, to improve long-term organizational performance and enhance stockholder value. A fundamental part of risk management
is not only understanding the risks a company faces and what steps management is taking to manage those risks, but also understanding
what level of risk is appropriate. In setting our business strategy, our Board assesses the various risks that now or in the future may
be faced by the Company and the degree to which they are being mitigated by management and determines what constitutes an appropriate
level of risk for us.
While
our Board has the ultimate oversight responsibility for the risk management process, various committees of our Board also have responsibility
for risk management in their areas of responsibility. The Audit Committee focuses on financial risk, including internal controls. Risks
related to our compensation programs are reviewed by the Compensation Committee and the Company’s overall compensation policies
covering all employees are meant to motivate employees with an effective balance between cash and equity compensation, focus on performance,
and improve our results on a cost-effective basis without encouraging excessive risk taking. Legal and regulatory compliance risks are
reviewed by the Nominating and Corporate Governance Committee. Our Board is advised by the Committees of significant risks and management’s
response via periodic updates.
Board
Composition
The
number of directors is currently set at three. The Board of Directors is divided into three classes, Class I, Class II and Class III,
which is divided as nearly equal in number as possible. Members of each class are elected to serve for staggered three-year terms. The
Company believes that a classified board of directors provides continuity and stability in pursuing the Company’s business strategies
and policies and reinforces the Company’s commitment to a long-term perspective and increases the Board’s negotiating leverage
when dealing with a potential acquirer. As discussed below under “Director Independence” a majority of the Board of Directors
of the Company are “independent” directors.
At
a minimum, Board members and candidates for membership on the Board of Directors must possess the experience, skills and background necessary
to gain a basic understanding of the principal operational and financial objectives and plans of the Company, the results of operations
and financial condition of our Company and its business segments and the relative standing of our Company and its business in relation
to its competitors. In addition, candidates must have a perspective that will enhance the Board’s strategic discussions and must
be capable of and committed to devoting adequate time to Board duties, including attendance at regularly-scheduled Board and Board Committee
meetings.
The
Nominating and Corporate Governance Committee reviews and assesses with the Board of Directors the specific skills, experience, and background
sought of Board members in the context of our business and the then-current membership on the Board. This assessment includes a consideration
of independence, diversity, skills, business experience, and personal and industry backgrounds. Although the Company does not have a
formal policy on diversity, as a matter of practice, the Nominating and Corporate Governance Committee strives to have a diverse set
of skills, experience and backgrounds represented on the Board in order to bring many different viewpoints to guide and assist management
of the Company. The Nominating and Corporate Governance Committee and the Board generally regard the following as key skills and experience
important for the Company’s Directors, as a group, to have in light of our current business and structure: senior leadership experience,
public company board experience, experience in financial markets and with financing transactions, knowledge of accounting and financial
reporting processes, experience in various industries relevant to the markets for the Company’s light-control technology, technical
knowledge relevant to our products, licensing, marketing and strategic planning expertise and legal education and experience.
Director
Independence
The
Board has determined that the following current directors of the Company are “independent” in accordance with applicable
listing standards of the NASDAQ Capital Market: Messrs. Daigle and Kaganowicz. Mr. Harary is employed as an executive officer of the
Company and does not qualify as independent.
The
NASDAQ Capital Market rules provide that a director cannot be considered independent if:
● | the
director is, or at any time during the past three years was, an employee of the company; |
| |
● | the
director or a family member of the director accepted any compensation from the company in
excess of $120,000 during any period of 12 consecutive months within the three years preceding
the independence determination (subject to certain exclusions, including, among other things,
compensation for board or board committee service); |
| |
● | a
family member of the director is, or at any time during the past three years was, an executive
officer of the company; |
| |
● | the
director or a family member of the director is a partner in, controlling stockholder of,
or an executive officer of an entity to which the company made, or from which the company
received, payments in the current or any of the past three fiscal years that exceed 5% of
the recipient’s consolidated gross revenue for that year or $200,000, whichever is
greater (subject to certain exclusions); |
| |
● | the
director or a family member of the director is employed as an executive officer of an entity
where, at any time during the past three years, any of the executive officers of the company
served on the compensation committee of such other entity; or |
| |
● | the
director or a family member of the director is a current partner of the Company’s outside
auditor, or at any time during the past three years was a partner or employee of the company’s
outside auditor, and who worked on the company’s audit. |
In
addition, an independent director must be a person who lacks a relationship that, in the opinion of the Board, would interfere with the
exercise of independent judgment in carrying out the responsibilities of a director. The Board has not established categorical standards
or guidelines to make these subjective determinations but considers all relevant facts and circumstances.
In
addition to the Board-level standards for director independence, the directors who serve on the Audit Committee each satisfy standards
established by the SEC providing that to qualify as “independent” for the purposes of membership on that committee, members
of audit committees may not accept directly or indirectly any consulting, advisory, or other compensatory fee from the company other
than their director compensation.
Board
Committees
The
Board of Directors has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The Board has
determined that each member of these committees is an “independent director” in accordance with applicable listing standards
of the NASDAQ Capital Market. The current members of the Audit Committee, Compensation Committee and Nominating and Corporate Governance
Committee are Messrs. Daigle and Kaganowicz.
Audit
Committee.
During
fiscal 2000, the Audit Committee of the Board of Directors developed a written charter for the Committee that was approved by the Board
of Directors which was updated in 2004 and was updated again in February 2009. The complete text of the Audit Committee’s current
charter is available on Company’s website at www.SmartGlass.com.
The
Audit Committee reviews and reports to the Board of Directors with respect to various auditing and accounting matters, including the
nomination of the Company’s independent registered public accountants, the scope of audit procedures, general accounting policy
matters and the performance of the Company’s independent registered public accountants. The Company believes that all members of
its Audit Committee, due to their backgrounds and business experience, are Audit Committee’s “financial expert” (as
such term is defined by applicable rules) and have a sufficient understanding of generally accepted accounting principles and financial
statements, the ability to assess the general application of such principles, an understanding of internal controls over financial reporting
and of audit committee functions to perform their duties as an Audit Committee.
Compensation
Committee.
During
fiscal 2014, the Compensation Committee of the Board of Directors developed a written charter for the Committee that was approved by
the Board of Directors in June 2014. The complete text of the Compensation Committee’s current charter is available on Company’s
website at www.SmartGlass.com.
The
Compensation Committee reviews and reports to the Board of Directors its recommendations for compensation of all employees and sets the
compensation of the management of the Company. In addition, each committee member is a “non-employee director” as defined
in Rule 16b-3 under the Exchange Act and an “outside director” as defined for purposes of Section 162(m) of the Internal
Revenue Code of 1986, as amended (the “Internal Revenue Code”).
The
Company’s Compensation Committee has the authority specified in Rule 5605(d)(3) which requires the compensation committees of Nasdaq-listed
companies to have specific responsibilities and authority with regard to compensation consultants, legal counsel, or other similar advisors
to the compensation committee. Specifically, the compensation committee must have sole discretion to retain such advisors, must be directly
responsible for oversight of their work, and must determine reasonable compensation to be paid to such advisors by the Company. Rule
5605(d)(3) also requires that the Compensation Committee may only select, or receive advice from, a compensation consultant, legal counsel,
or other advisor after taking into consideration the following factors:
|
● |
the
provision of other services to the company by the person that employs the compensation consultant, legal counsel or other advisor; |
|
|
|
|
● |
the
amount of fees received from the company by the person that employs the compensation consultant, legal counsel or other advisor,
as a percentage of the total revenue of the person that employs the compensation consultant, legal counsel or other advisor; |
|
|
|
|
● |
the
policies and procedures of the person that employs the compensation consultant, legal counsel or other advisor that are designed
to prevent conflicts of interest; |
|
|
|
|
● |
any
business or personal relationship of the compensation consultant, legal counsel or other advisor with a member of the compensation
committee; |
|
|
|
|
● |
any
stock of the company owned by the compensation consultant, legal counsel or other advisor; and |
|
|
|
|
● |
any
business or personal relationship of the compensation consultant, legal counsel, other advisor or the person employing the advisor
with an executive officer of the company. |
Nominating
and Corporate Governance Committee.
The
Nominating and Corporate Governance Committee is responsible for overseeing the governance practices of the Company and for making recommendations
to the Board for any modifications to such practices. It also identifies individuals qualified to become Board members and recommends
to the Board the director nominees for the next annual meeting of stockholders and candidates to fill vacancies on the Board. Additionally,
the committee recommends to the Board the directors to be appointed to Board committees. Because the Board of Directors of the Company
has a majority of independent directors, these independent directors control the Board of Directors’ selection of nominees for
director. The Nominating and Corporate Governance Committee is not required to, and does not have, a written charter.
The
Nominating and Corporate Governance Committee considers candidates for Board membership suggested by its members and by other Board members.
The Nominating and Corporate Governance Committee may also engage the services of a director candidate search consultant. In that case,
the director candidate search consultant will seek out candidates who have the experiences, skills, and characteristics that the Nominating
and Corporate Governance Committee has determined are necessary to serve as a member of the Board and then present the most qualified
candidates to the Nominating and Corporate Governance Committee and the Company’s management.
Once
a prospective nominee has been identified, the Nominating and Corporate Governance Committee makes an initial determination as to whether
to conduct a full evaluation of the candidate. This initial determination is based on the information provided to the committee with
the recommendation of the prospective candidate, as well as the committee’s own knowledge of the prospective candidate, which may
be supplemented by inquiries of the person making the recommendation or others. The initial determination is based primarily on the need
for additional Board members to fill vacancies or expand the size of the Board and the likelihood that the prospective nominee can satisfy
the evaluation factors described under the heading “Board Composition” above. The committee then evaluates the prospective
nominee and his or her qualifications, as well as other factors which may include such things as whether the prospective nominee meets
the independence requirements and other qualifications or criteria set forth under applicable listing standards of the NASDAQ Capital
Market, or other requirements defined under applicable SEC rules and regulations; the extent to which the prospective nominee’s
skills, experience and perspective add to the range of talent appropriate for the Board and whether such attributes are relevant to the
Company’s industry; the prospective nominee’s ability to dedicate the time and resources sufficient for the diligent performance
of Board duties; and the extent to which the prospective nominee holds any position that would conflict with responsibilities to the
Company.
If
the Nominating and Corporate Governance Committee’s internal evaluation is positive, the committee and possibly others will interview
the candidate. Upon completion of this evaluation and interview process, the Nominating and Corporate Governance Committee makes a recommendation
and report to the full Board as to whether the candidate should be nominated by the Board and the Board determines whether to approve
the nominee after considering this recommendation and report.
Additionally,
in selecting nominees for directors, the Nominating and Corporate Governance Committee will review candidates recommended by stockholders
in the same manner and using the same general criteria as candidates recruited by the committee and/or recommended by the Board. The
Nominating and Corporate Governance Committee will also consider whether any person nominated by a stockholder has been so nominated
on a timely basis and in accordance with the provisions of the Company’s By-Laws relating to stockholder nominations and other
applicable provisions including those described in “2022 Stockholder and Director Nominations” below.
2023
STOCKHOLDER AND DIRECTOR NOMINATIONS
Attendance
at Board, Committee, and Annual Stockholders’ Meetings
During
2022, the Company’s Board of Directors met eight times, the Board’s Audit Committee met four times and also met several
times informally, the Board’s Compensation Committee met eight times, and the Board’s Nominating and Corporate Governance
Committee met six times. No incumbent director attended less than 75% of meetings of the full Board of Directors and of the Board committee(s)
of which that director was a member during 2022. The Company encourages and expects all of its directors to attend its Annual Meeting
of Stockholders in person or remotely, and all incumbent directors attended last year’s Annual Meeting of Stockholders.
Executive
Officers
In
addition to Joseph M. Harary, whose biographical information is provided above, the only other executive officer of the Company is Michael
R. LaPointe.
Michael
R. LaPointe
Michael
R. LaPointe, age 64, joined the Company as its Director of Marketing for Architectural Windows and Displays in March 2000 and served
as the Company’s Vice President - Marketing from March 2002 until he became the Company’s Vice President-Aerospace Products
in July 2013. Mr. LaPointe, a graduate of Brown University with a B.A. in Organizational Behavior & Management and a B.A. in Psychology,
worked in a marketing capacity for IBM Corporation in the early 1980s. He subsequently founded and developed several companies involved
in the application and licensing of new technologies for various consumer products. During that period Mr. LaPointe also worked as a
management consultant, where in 1994 he began his relationship with the Company, assisting the Company with its marketing strategy.
Compensation
Committee Interlocks and Insider Participation
In
2022, the Compensation Committee of our Board of Directors consisted solely of independent directors. None of the Company’s executive
officers served as a director or member of the compensation committee of another entity which had an executive officer that served as
a director or member of the Company’s Compensation Committee. No member of the Company’s Compensation Committee is a current
or former employee of the Company.
INDEPENDENT
REGISTERED PUBLIC ACCOUNTANTS
(Item
2)
The
Audit Committee, with the concurrence of the Board of Directors, has selected the firm of CohnReznick LLP to serve as our independent
registered public accountants for the fiscal year ending December 31, 2023. We expect that representatives of CohnReznick will attend
the meeting, have the opportunity to make a statement if they so desire, and be available to respond to appropriate questions.
Audit
and Other Fees
The
following table presents fees paid or accrued for professional audit services rendered by the Company’s independent registered
public accountants for the audit of our annual financial statements for the years ended December 31, 2022 and December 31, 2021, and
fees billed to us for other services rendered by CohnReznick during these periods:
| |
2022 | | |
2021 | |
| |
| | |
| |
Audit
Fees (1) | |
$ | 132,090 | | |
$ | 119,850 | |
Tax
Fees (2) | |
| 13,464 | | |
| 14,840 | |
Total | |
$ | 145,554 | | |
$ | 134,690 | |
(1) |
Audit
fees include fees for the audit of the Company’s annual financial statements, review of financial statements included in the
Company’s Form 10-Q Quarterly Reports, and services that are normally provided by the independent registered public accountants
in connection with regulatory filings for those fiscal years. |
|
|
(2) |
Tax
fees include fees for all services performed by the independent registered public accountants’ tax personnel except those services
specifically related to the audit of the financial statements and includes fees for tax compliance and tax advice. |
The
Audit Committee has approved the above-listed fees, has considered whether the provision of the tax services described above is compatible
with maintaining such accounting firms’ independence, and has determined that the provision of such services is compatible with
maintaining such accounting firms’ independence.
The
Board of Directors recommends a vote FOR ratification of the selection of the accounting firm of CohnReznick LLP as independent registered
public accountants of the Company for the fiscal year ending December 31, 2023.
ADVISORY
RESOLUTION ON EXECUTIVE COMPENSATION
(Item
3)
In
accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank”) and section 14A of the Exchange
Act, we are providing stockholders with the opportunity to cast a vote on an advisory resolution on the Company’s executive compensation
as reported in this Proxy Statement. Our executive compensation programs are designed to support the Company’s long-term success.
As described below in the “Compensation Discussion and Analysis” section of this Proxy Statement, the Compensation Committee
has structured our executive compensation program to achieve the following key objectives:
|
● |
provide
total compensation packages to our executives that are competitive with our peer companies; |
|
● |
attract,
retain and motivate executive officers who have the skills, experience and knowledge important to the success of the Company; |
|
|
|
|
● |
reward
superior performance and encourage actions that drive our business strategy; and |
|
|
|
|
● |
align
total executive compensation with the long-term performance of the Company and the interests of its stockholders and enable our executives
to participate in the Company’s growth. |
The
Company believes that our performance-based executive compensation programs provide incentives that are aligned with the interests of
our stockholders and have facilitated the Company’s performance. We urge stockholders to read the “Compensation Discussion
and Analysis” below, which describes in more detail how our executive compensation policies and procedures operate and are designed
to achieve our compensation philosophy and objectives, as well as the Summary Compensation Table and related compensation tables and
narrative below which provide detailed information on the compensation of our named executive officers. The Compensation Committee and
the Board of Directors believe that the policies and procedures articulated in the “Compensation Discussion and Analysis”
are effective in achieving our goals and that the compensation of our named executive officers reported in this Proxy Statement has supported
and contributed to the Company’s success.
We
are asking stockholders to approve the following advisory resolution at the 2023 Annual Meeting:
RESOLVED,
that the stockholders of Research Frontiers Incorporated (the “Company”) approve, on an advisory basis, the compensation
of the Company’s named executive officers set forth in the Compensation Discussion and Analysis, the Summary Compensation Table
and the related compensation tables and narrative in the Proxy Statement for the Company’s 2023 Annual Meeting of Stockholders.
This
advisory resolution, commonly referred to as a “say-on-pay” resolution, is non-binding on the Board of Directors. Although
non-binding, the Board and the Compensation Committee will carefully review and consider the voting results when evaluating our executive
compensation program.
The
Board of Directors recommends a vote FOR the advisory resolution approving the compensation of the Company’s named executive officers
set forth in the Compensation Discussion and Analysis, the Summary Compensation Table and the related compensation tables and narrative
in the Proxy Statement, and it is intended that proxies not marked to the contrary will be so voted.
ADVISORY
VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES
ON
EXECUTIVE COMPENSATION
(Item
4)
We
will provide an advisory vote on executive compensation at least once every three years. In accordance with Dodd-Frank and section 14A
of the Exchange Act, we are providing stockholders the chance to vote on whether future advisory votes on executive compensation should
occur every year, every two years or every three years.
After
careful consideration, the Board of Directors recommends that future advisory votes on executive compensation occur every three years
(triennially).
We
believe that this frequency is appropriate for a number of reasons, including:
| ● | Our
compensation programs have not typically changed significantly from year to year and we seek
to be consistent; |
| | |
| ● | A
longer frequency is consistent with long-term compensation objectives; and |
| | |
| ● | A
three year cycle gives the Board of Directors and the Compensation Committee sufficient time
to evaluate the results of the most recent |
advisory
vote on executive compensation, to discuss the implications of that vote with stockholders to the extent needed, to engage compensation
experts to the extent needed, and to develop and implement any adjustments to our executive compensation programs that may be appropriate
in light of a past advisory vote on executive compensation.
For
the foregoing reasons, we encourage our stockholders to evaluate our executive compensation programs over a multi-year horizon and to
review our named executive officers’ compensation over the past three fiscal years as reported in the Summary Compensation Table
below. We believe that holding an advisory vote on executive compensation every three years will reflect the right balance of considerations
in the normal course, and we will periodically reassess that view and can provide for an advisory vote on executive compensation on a
more frequent basis if changes in our compensation programs or other circumstances suggest that such a vote would be appropriate.
Stockholders
will be able to specify one of four choices for this proposal on the proxy card: three years, two years, one year or abstain. Stockholders
are not voting to approve or disapprove the Board’s recommendation. This advisory vote on the frequency of future advisory votes
on executive compensation is non-binding on the Board of Directors. Notwithstanding the Board of Director’s recommendation and
the outcome of the stockholder vote, the Board of Directors may in the future decide to conduct advisory votes on a more or less frequent
basis and may vary its practice based on factors such as discussions with stockholders and the adoption of material changes to compensation
programs.
The
Board of Directors recommends that you vote to conduct future advisory votes on executive compensation every THREE years, and it is intended
that proxies not marked to the contrary will be so voted.
AUDIT
COMMITTEE REPORT
The
following Audit Committee Report does not constitute soliciting material and should not be deemed filed or incorporated by reference
into any other Company filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except
to the extent the Company specifically incorporates this Report by reference therein.
The
Audit Committee of the Board is responsible for providing independent, objective oversight of the Company’s accounting functions
and internal controls. The Audit Committee’s duties specifically include the appointment, compensation and supervision of the Company’s
independent registered public accountants, as well as pre-approval of all auditing and non-auditing services provided by the Company’s
independent registered public accounting firm. Management is responsible for the Company’s internal controls and financial reporting
process. The independent registered public accountants are responsible for performing an independent audit of the Company’s financial
statements and its internal controls over financial reporting, if applicable, in accordance with the standards of the Public Company
Accounting Oversight Board, and to issue a report thereon. As set forth in more detail in its charter, the Audit Committee’s responsibility
is to monitor and oversee these processes.
The
Audit Committee has discussed with the independent registered public accounting firm the matters required by the applicable requirements
of the Public Company Accounting Oversight Board and the SEC. In connection with these responsibilities, the Audit Committee met with
management and the Company’s independent registered public accountants, to review and discuss all financial statements included
in the Company’s quarterly and annual reports for the fiscal year ended December 31, 2022 (the “Financial Statements”)
prior to their issuance and to discuss significant accounting issues. Management has advised us that the Financial Statements were prepared
in accordance with generally accepted accounting principles, and the Committee discussed the Financial Statements with both management
and the independent registered public accountants.
The
Audit Committee also received written disclosures and the letter from the independent registered public accountants required by applicable
requirements of the PCAOB Rule 3526 regarding the independent accountant’s communications with the Audit Committee concerning independence
and has discussed with the independent registered public accountants that firm’s independence. Finally, the Audit Committee continued
to monitor the integrity of the Company’s financial reporting processes and its internal procedures and controls.
Based
upon the Audit Committee’s discussions with management and the independent registered public accountants, and the Audit Committee’s
review of the representations of management and the independent registered public accountants, the Audit Committee recommended to the
Board of Directors that the Company’s audited financial statements be included in the Company’s Annual Report on Form 10-K
for the fiscal year ended December 31, 2022, for filing with the SEC.
|
Members
of the Audit Committee: |
|
|
|
Darryl
Daigle (Chairman) |
|
Alexander
Kaganowicz |
COMPENSATION
DISCUSSION AND ANALYSIS
Overview
This
Compensation Discussion and Analysis (“CD&A”) provides an overview of the Company’s executive compensation program
including our philosophy, key program elements, the decisions made under the program and the factors that were considered in making those
decisions. The commentary in the CD&A is intended to facilitate an understanding of the data found in the accompanying compensation
tables.
This
Compensation Discussion and Analysis primarily addresses the compensation of our Named Executive Officers listed below:
Joseph
M. Harary, President and Chief Executive Officer
Michael
R. LaPointe, Vice President – Aerospace Products
The
foregoing named executive officers comprise all of our executive officers. These two executive officers are referred to as the “named
executive officers” throughout this Proxy Statement.
Our
executive compensation program is intended to drive results, recognize contributions to the success of our company, and retain leadership
talent. Our executive officers have shown solid leadership in the developments and commercialization of the Company’s proprietary
SPD technology. The Company believes that the continued development of our growth strategy will be the key factor to establishing strong
financial performance for shareholders in the future.
Our
Compensation Philosophy and Objectives
The
Company seeks to include in compensation for the Company’s executive officers a combination of base salary, equity incentives,
and performance-based bonuses that is intended to attract, retain and motivate executive officers who have the skills, experience and
knowledge important to the success of the Company and to reward superior performance and encourage actions that drive our business strategy.
The objective of this approach is to align total executive compensation with the long-term performance of the Company and the interests
of its stockholders and enable employees of the Company to participate in the Company’s growth. Through ownership of stock and
options, the Company believes that executive officers are rewarded if the Company’s stockholders receive the benefit of appreciation
of the price of the Common Stock.
The
Compensation Committee reviewed and evaluated the Company’s executive and non-executive compensation policies and practices,
including, specifically, the mix between salary and bonus, cash and equity, short-term and long-term incentives, and the use of
performance measures and discretion with respect to individual awards. The Compensation Committee also evaluated how the
Company’s compensation policies and practices could encourage excessive risk taking and how the Company’s policies and
practices are structured to mitigate any such risks. In this regard, the Compensation Committee considered the following: (i) while
base salary is the primary component of total compensation for most of the Company’s employees and such salaries are generally
competitive, the Company has attempted to better align the interests of its executive officers and its stockholders by increasingly
emphasizing incentive compensation for its executive officers, (ii) the Compensation Committee believes that the Company’s
incentive plans for senior management, executive officers and its employees include an appropriate mix of short-term and long-term
performance incentives and cash and equity compensation, (iii) the Compensation Committee
believes that the goals and objectives in the Company’s incentive plans are reasonable and do not incentivize employees to
take excessive risks, and (iv) the Company has one business unit so that there does not exist the risk that (A) any one business
unit of the Company carries a significant portion of the Company’s risk profile, (B) is significantly more profitable than
other business units within the Company, or (C) that the compensation structure is inconsistent among business units. As a result of
this review and evaluation, the Compensation Committee concluded that any risks that may result from the Company’s
compensation policies and practices are not reasonably likely to have a material adverse effect on the Company.
Role
of the Compensation Committee in Compensation Decisions
The
compensation of executive officers of the Company, including its named executive officers, is determined by the Compensation Committee
of the Company’s Board of Directors. The salaries of all executive officers are also reviewed at least annually by the Compensation
Committee and by the entire Board of Directors. Numerous factors are reviewed in determining compensation levels. These factors include:
the compensation levels of executive officers with comparable experience and qualifications, compensation levels at comparable companies,
individual and Company performance, past compensation levels, building stockholder value, and other relevant considerations, including
a review of applicable compensation studies and other reference materials.
Compensation
Consultants and Benchmarking
The
Compensation Committee believes that it is neither necessary nor cost-effective to hire advisors to benchmark the structure and level
of its executive officer compensation on an annual basis. However, from time to time, the Compensation Committee retains compensation
consultants to advise it and compare the Company’s compensation practices versus similar companies. In 2022, the Company did not
retain a compensation consultant.
In
2011, the Company retained Connell & Partners to analyze and compare the compensation of independent directors and of Mr. Harary
against the compensation paid by a peer group of publicly-traded companies (the “Peer Group”). The Compensation Committee
used the companies in the Peer Group based on its belief that they are similar to the Company in terms of business type, employee skill
sets, revenue, and market capitalization.
The
Company updated the Peer Group information with compensation data that was reported during 2022 and 2023. This updated
compensation data for the Peer Group was considered by the Compensation Committee when evaluating the executive compensation for Mr.
Harary. The following companies were included in the updated Peer Group:
Peer
Company |
|
Ticker |
Arrowhead
Pharmaceuticals, Inc. |
|
ARWR |
Autoscope
Technologies Corp. |
|
AATC |
Aware,
Inc. |
|
AWRE |
Creative
Realities, Inc. |
|
CREX |
eMagin
Corp. |
|
EMAN |
Innovative
Solutions and Support, Inc. |
|
ISSC |
Mesa
Laboratories, Inc. |
|
MLAB |
Microvision,
Inc. |
|
MVIS |
ParkerVision,
Inc. |
|
PRKR |
PCTEL,
Inc. |
|
PCTI |
Perasco |
|
PRSO |
PowerFleet,
Inc. |
|
PWFL |
PURE
Bioscience, Inc. |
|
PURE |
Riot
Blockchain, Inc. |
|
RIOT |
Not
all of the fourteen Peer Group companies had reported
their compensation data as of the record date for last year’s or this year’s annual meeting. As consequence, the following
Compensation Analysis will consider only the most recently reported compensation data for all the Peer Group companies that have
reported their compensation data as of the record date for this year’s Annual Meeting.
Compensation
Analysis:
The
Compensation Committee reviewed and compared the following components of Mr. Harary’s compensation to that of executive officers
serving in similar roles for companies in our compensation peer group: (1) base salary; (2) actual total cash compensation (base salary
plus actual bonus); (3) long-term incentive compensation (fair value of stock options, restricted shares, and performance-based long-term
incentive plans, annual equity participation (annual shares granted as a percent of shares outstanding); and (4) actual total direct
compensation (actual total cash plus long-term incentive compensation) (“ATDC”). The following sets forth, as a percentage
of ATDC, the first four of the aforementioned compensation components with respect to Mr. Harary as compared to that of our peer group.
2021
Compensation:
Base
Salary:
Mr.
Harary’s base salary in 2021 was $500,000. Base salary for executive officers performing similar roles for peer group members ranged
from $270,000 to $837,031 with an average of $351,786. Mr. Harary’s base salary in 2021 represents 75% of his ATDC. Base salary
as a percentage of ATDC for executive officers performing similar roles for Peer Group CEO Executives ranged from 0% to 96% with an average
of 35%.
Actual
Total Cash Compensation:
Mr.
Harary’s actual total cash compensation in 2021 was $608,599. Actual total cash compensation for executive officers performing
similar roles for Peer Group CEO Executives ranged from $64,000 to $1,684,855 with an average of $541,311. Mr. Harary’s actual
total cash compensation in 2021 as a percentage of his ATDC was 91%. Actual Total Cash Compensation as a percentage of ATDC for executive
officers performing similar roles for Peer Group CEO Executives ranged from 7% to 100% with an average of 51%.
Long-Term
Incentive Compensation:
Mr.
Harary’s long-term incentive compensation in 2021 was $60,500. Long-term incentive compensation for Peer Group CEO Executives ranged
from $0 to $23,019,000 with an average of $3,232,163. Mr. Harary’s long-term incentive compensation in 2021 as a percentage of
his ATDC was 9%. Long-term incentive compensation as a percentage of ATDC for executive officers performing similar roles for Peer Group
CEO Executives ranged from 0% to 93% with an average of 49%.
Actual
Total Direct Compensation:
Mr.
Harary’s actual total direct compensation in 2021 was $669,099. Actual total direct compensation for Peer Group CEO Executives
ranged from $164,000 to $24,703,855 with an average of $3,773,474.
The
Compensation Committee, having met and deliberated eight times during 2021, believes that the current compensation approach and level
of compensation of the Company’s named executive officers is appropriate and in the best interests of the Company and its stockholders.
2022
Compensation:
Base
Salary:
Mr. Harary’s base salary in 2022 was $600,000.
Base salary for executive officers performing similar roles for peer group members ranged from $260,000 to $863,417 with
an average of $396,270. Mr. Harary’s base salary in 2022 represents 81% of his ATDC. Base salary as a percentage of ATDC
for executive officers performing similar roles for Peer Group CEO Executives ranged from 0% to 90% with an average of 36%.
Actual
Total Cash Compensation:
Mr. Harary’s actual total cash compensation
in 2022 was $661,154. Actual total cash compensation for executive officers performing similar roles for Peer Group CEO Executives ranged
from $74,000 to $1,721,368 with an average of $697,331. Mr. Harary’s actual
total cash compensation in 2022 as a percentage of his ATDC was 89%. Actual Total Cash Compensation as a percentage of ATDC for executive
officers performing similar roles for Peer Group CEO Executives ranged from 3% to 100% with an average of 55%.
Long-Term
Incentive Compensation:
Mr.
Harary’s long-term incentive compensation in 2022 was $78,600. Long-term incentive compensation for Peer Group CEO Executives ranged
from $0 to $16,417,012 with an average of $4,331,373. Mr. Harary’s long-term incentive compensation in 2022 as a
percentage of his ATDC was 11%. Long-term incentive compensation as a percentage of ATDC for executive officers performing similar roles
for Peer Group CEO Executives ranged from 0% to 97% with an average of 45%.
Actual
Total Direct Compensation:
Mr. Harary’s actual total direct compensation
in 2022 was $739,754. Actual total direct compensation for Peer Group CEO Executives ranged from $74,000 to $21,876,868
with an average of $5,028,705.
The
Compensation Committee, having met and deliberated eight times during 2022, believes that the current compensation approach and level
of compensation of the Company’s named executive officers is appropriate and in the best interests of the Company and its stockholders.
Components
of Named Executive Officer Compensation
The
principal components of compensation for the named executive officers are base salary, performance-based annual cash compensation and
long-term equity compensation. The Compensation Committee seeks to achieve a mix of these components such that total compensation is
competitive in the marketplace. Historically, the Company’s compensation program focused on base salary as a primary means to compensate
its named executive officers. In recent years, the Company has relied increasingly on short-term and long-term incentive compensation
to better align the interests of the named executive officers with the interests of stockholders in both short-term and long-term growth.
The Company continues to transition its compensation program from its historical base salary orientation to a program with an increasing
emphasis on incentive compensation. The Compensation Committee does not have a formal policy for allocation between cash and non-cash
or short-term and long-term incentive compensation. The following table shows the components of named executive officer compensation:
Component |
|
Purpose |
|
Characteristics
|
Base
Salary |
|
Compensate
named executive officers for performing their roles and assuming their levels of executive responsibility. Intended to provide a
competitive level of compensation, it is a necessary component in recruiting and retaining executives. |
|
Fixed
component. Annually reviewed and adjusted as appropriate. |
Performance-based
Annual Incentive Compensation |
|
Promote
the achievement of short-term business and financial goals. Align named executive officers and stockholder interests in the short-
term performance of the Company and reward named executive officers for superior Company performance during the
short-term. |
|
Performance-based
bonus opportunity based on the achievement of certain goals, which may be individual performance goals, Company performance goals
or a combination of the two. |
Long-Term
Equity Compensation |
|
Promote
the achievement of the Company’s long-term financial goals and increases in value for the Company’s stockholders. Align
named executive officers and stockholder interests, promote named executive officers’ retention and reward named executive
officers for superior Company performance over time. |
|
Reviewed
annually and granted, if appropriate, in the form of stock options and stock awards. |
Base
Salary. The amount of base salary for any executive officer is based on the level of responsibility of the executive officer, the
Company’s performance, the executive officer’s individual performance and the executive officer’s compensation compared
to similarly situated executives in the Compensation Peer Group. As mentioned above, historically the Company’s compensation program
has focused on base salary as its primary compensation element. Base salary is an important element in recruiting and retaining executive
officers.
Performance-based
Annual Incentive Compensation. To better align our compensation practices with the market and to promote the achievement of short-term
business and financial goals, the Compensation Committee has increasingly emphasized bonus opportunities for its executive officers in
the form of performance-based annual incentive compensation.
A
portion of Mr. Harary’s 2022 compensation was tied to the achievement of various business and financial goals during the year.
Under his employment agreement, Mr. Harary is eligible to earn a cash bonus based upon the achievement of performance goals established
by the Board. As set forth below, the performance goals established by the Board for 2022 were divided into two main categories and,
at the end of the performance period, the Compensation Committee determined the extent to which the pre-established performance goals
were satisfied during the performance period.
For
2022, Mr. Harary’s target bonus was based on: (i) the achievement of revenue goals, and (ii) the achievement of other non-revenue
performance objectives. The amount of compensation awarded for 2022 to Mr. Harary as a bonus is reflected in the “Non-Equity Incentive
Plan Compensation” column of the “Summary Compensation Table” below.
A
cash bonus may be awarded to any officer of the Company at the discretion of the Board and Compensation Committee for extraordinary individual
achievement or for other reasons. The Board paid Mr. LaPointe a bonus of $3,000 for the achievement of certain other performance and
strategic goals for the entire Company and their efficient implementation and management in 2022. The amount of compensation awarded
for 2022 to Mr. LaPointe as a bonus is reflected in the “Non-Equity Incentive Plan Compensation” column of the “Summary
Compensation Table” below.
Long-Term
Equity Compensation. The Company uses long-term equity compensation to provide incentives to those most responsible for the Company’s
success, to promote the achievement of the Company’s long-term financial goals and to align the interests of its executive officers,
employees and consultants with that of its stockholders. The award of long-term equity compensation also assists the Company in attracting
and retaining executive officer talent and reduces the amount of cash compensation that would otherwise be necessary to do so. The Company
has granted equity awards to executive officers in the form of stock options or restricted stock under the Company’s 2019 Equity
Incentive Plan (the “2019 Plan”) and its predecessor plan, the 2008 Stock Option Plan (which expired in April 2018).
The
Compensation Committee does not employ quantitative criteria or performance measures from year to year in the granting of equity awards.
Rather, the form and amount of equity awards are based on a subjective determination by the Compensation Committee of the effectiveness
of each named executive officer and the extent of his contributions to the Company. The Company seeks to emphasize equity compensation
to better align the interests of its named executive officers and stockholders and to promote the retention of its named executive officers.
Accordingly, the Company awards long-term equity awards at levels it believes reflect these goals.
The
Compensation Committee and Board believe that an equity incentive plan is essential to the Company’s continued success. The purpose
of such equity incentive plans is to afford an incentive to executive officers, other employees, non-employee directors and consultants
of the Company to acquire a proprietary interest in the Company, to continue as employees, non-employee directors or consultants (as
the case may be), to increase their efforts on behalf of the Company and to promote the success of the Company’s business. The
Compensation Committee and Board believe that the granting of equity incentive awards will promote continuity of management, help attract
new employees, and encourage employees, directors, officers and consultants, to increase their stock ownership in the Company and provide
an increased incentive and personal interest in the welfare of the Company by those who are or may become primarily responsible for shaping
and carrying out the long range plans of the Company and securing its continued growth, development and financial success. To further
such purposes, stock options, stock appreciation rights, restricted stock and restricted stock units may be granted pursuant to such
equity incentive plans. The Company has relied primarily on stock option grants and awards of restricted stock under its prior equity
incentive plans to compensate named executive officers. The Company has not awarded stock appreciation rights or restricted stock units.
During
2022, the Compensation Committee awarded option awards to its named executive officers as set forth in the “Grants of Plan-Based
Awards in 2022” table below.
Employment
Arrangements
In
2009, the Company entered into a five-year employment agreement with Joseph M. Harary, which was effective as of January 1, 2009 when
Mr. Harary was promoted to the position of Chief Executive Officer of the Company. Pursuant to that agreement, in addition to possible
future equity incentive awards granted by the Board of Directors of the Company in their discretion, Mr. Harary received 150,000 shares
of restricted stock of the Company which vested monthly over a three-year period. An amendment to this agreement was executed effective
as of September 26, 2019 between the Company and Joseph M. Harary which extended the agreement through December 31, 2024. The agreement
automatically renews itself for successive one-year terms unless either the Company or Mr. Harary gives the other at least 90 days prior
written notice of the intention not to renew the employment agreement prior to its expiration. Mr. Harary received an annual base salary
from the Company of $600,000 in 2022 and will receive an annual base salary of $500,000 in 2023. In addition, Mr. Harary will be eligible
to also earn a discretionary bonus based upon the achievement of performance goals established by the Board of Directors. Pursuant to
his employment agreement, if Mr. Harary’s employment is terminated due to his death or disability, Mr. Harary shall be entitled
to receive his base salary (less any disability payments) for six months as well as any earned or accrued bonus. If Mr. Harary’s
employment is not renewed or is terminated by the Company other than due to death, disability, or for cause (as defined in the agreement)
prior to its scheduled expiration date, then Mr. Harary shall also receive his base salary for between one and three years, depending
upon the date of such termination. If there is a change in control of the Company, Mr. Harary shall receive his base salary for the longer
of three years or the scheduled date of termination of Mr. Harary’s employment agreement. Unless vesting is otherwise accelerated
under the terms of an equity award (which is usually done in the case of death or disability of an employee), if Mr. Harary’s employment
is terminated by the Company in breach of his employment agreement or is terminated by Mr. Harary other than for good reason (as defined
in the agreement), any unvested equity awards shall also become immediately vested. Pursuant to the employment agreement, Mr. Harary
is also entitled to four weeks paid vacation each year, and other fringe benefits generally applicable to other employees of the Company.
Under his employment agreement, Mr. Harary has also agreed to certain restrictive covenants including Mr. Harary’s agreement not
to solicit employees or compete with the Company for a period of two years following the termination of his employment thereunder.
The
Company does not have employment agreements, written or unwritten, with its other executive officer, Mr. LaPointe.
COMPENSATION
COMMITTEE REPORT
The
following Compensation Committee Report does not constitute soliciting material and should not be deemed filed or incorporated by reference
into any other Company filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except
to the extent the Company specifically incorporates this Report by reference therein.
The
Compensation Committee of the Board of Directors of the Company has reviewed and discussed with management the Compensation Discussion
and Analysis included in this Proxy Statement. Based on its reviews and discussions, the Committee recommended to the Board of Directors
that the Compensation Discussion and Analysis be included in this Proxy Statement and incorporated by reference into the Company’s
Annual Report on Form 10-K for the year ended December 31, 2022.
This
report is submitted on behalf of the Compensation Committee.
|
Members
of the Compensation Committee |
|
|
|
Darryl
Daigle (Chairman) |
|
Alexander
Kaganowicz |
EXECUTIVE
COMPENSATION TABLES
Summary
Compensation Table
The
following table sets forth information regarding each element of compensation that we pay or award to our named executive officers. The
Company has not and does not currently provide, and has no plan to provide in the future, pension benefits, non-qualified defined contributions,
or deferred contributions.
Name
and | |
| |
Salary | | |
Bonus | | |
Stock/Option
Awards | | |
Non-Equity
Incentive Plan Compensation | | |
All
Other
Compensation | | |
Total
($) | |
Principal
Position | |
Year | |
($) | | |
($) | | |
($)(1) | | |
($) | | |
($)(2) | | |
(3) | |
| |
| |
| | |
| | |
| | |
| | |
| | |
| |
Joseph
M. | |
2022 | |
| 600,000 | | |
| - | | |
| 78,600 | | |
| 15,000 | | |
| 46,154 | | |
| 739,754 | |
Harary,
President | |
2021 | |
| 500,000 | | |
| - | | |
| 60,500 | | |
| 70,137 | | |
| 38,462 | | |
| 671,457 | |
and
Chief Executive Officer | |
2020 | |
| 500,000 | | |
| - | | |
| 90,750 | | |
| 42,245 | | |
| 38,462 | | |
| 804,605 | |
| |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Michael
R. LaPointe, | |
2022 | |
| 40,000 | | |
| - | | |
| 7,860 | | |
| 3,000 | | |
| - | | |
| 50,860 | |
Vice
President-Marketing | |
2021 | |
| 40,000 | | |
| - | | |
| 5,500 | | |
| 2,000 | | |
| - | | |
| 58,669 | |
| |
2020 | |
| 40,000 | | |
| - | | |
| 8,250 | | |
| 10,419 | | |
| - | | |
| 72,548 | |
|
(1) |
Amounts in this column represent
stock options issued in 2022, 2021 and 2020 (no restricted stock awards were issued during this period). The dollar value of
option awards listed in this column are estimated grant date fair values based upon the Black-Scholes valuation method in accordance
with Financial Accounting Standards Board Accounting Standard Codifications Topic 718 (“ASC 718”) and using the assumptions
set forth in the Company’s Annual Report on Form 10-K for the respective year in question. |
|
|
|
|
(2) |
Consists of cash payments of accrued but unused vacation and
other taxable benefits. |
|
|
|
|
(3) |
Consists of cash compensation (salary, bonus, and accrued vacation)
plus non-equity incentive compensation and the estimated grant date fair value of stock and option awards calculated based upon the valuation
methods described in footnote (1) above. These amounts do not indicate the amount received by the individual since estimated values will
fluctuate based upon future market conditions. |
Grants
of Plan-Based Awards in 2022
The
table below provides information regarding payment of non-equity incentive plan compensation and awards of stock options pursuant to
the 2019 Equity Incentive Plan (the “2019 Plan”) to the named executive officers of the Company.
| |
| |
Estimated
Possible Payouts under Non-Equity Incentive Plan Awards (1) | | |
All Other Equity Awards:
Number of | | |
Grant
Date Fair Value of Stock and Option | | |
Closing
Stock | | |
Restricted | |
Name | |
Grant
Date | |
Threshold
($) | | |
Target
($) | | |
Maximum
($) | | |
Options
(#) (2) | | |
Awards
($) | | |
Price
($) | | |
Stock
Grant | |
Joseph
M. Harary | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
12/31/2022 | |
| - | | |
| - | | |
| - | | |
| 60,000 | | |
| 78,600 | | |
| 1.91 | | |
| - | |
| |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Michael
R. LaPointe | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
12/31/2022 | |
| - | | |
| - | | |
| - | | |
| 6,000 | | |
| 7,860 | | |
| 1.91 | | |
| - | |
|
(1) |
These columns report the range of cash payouts for 2022 performance
under Mr. Harary’s employment agreement as described in the Compensation Discussion and Analysis. |
|
|
|
|
(2) |
Represents awards of stock options made under the 2019 Plan. |
Outstanding
Equity Awards at December 31, 2022
The
following table shows all options outstanding as of the end of 2022 that have been granted to named executive officers of the Company.
All options were fully vested and exercisable as of the end of 2022.
| |
Option
Awards | | |
| | |
| |
|
| |
Number
of Securities Underlying Unexercised | | |
Option | | |
| |
Option |
| |
Options
(#) | | |
Exercise
Price | | |
Option Grant | |
Expiration |
Name | |
Exercisable | | |
($) | | |
Date | |
Date |
| |
| | |
| | |
| |
|
Joseph
M. Harary | |
| 119,400 | | |
| 5.56 | | |
12/31/2013 | |
12/30/2023 |
| |
| 59,700 | | |
| 5.19 | | |
12/31/2014 | |
12/30/2024 |
| |
| 55,000 | | |
| 2.785 | | |
12/31/2020 | |
12/30/2030 |
| |
| 55,000 | | |
| 1.72 | | |
12/31/2021 | |
12/30/2031 |
| |
| 60,000 | | |
| 1.95 | | |
12/31/2022 | |
12/20/2032 |
| |
| 349,100 | | |
| | | |
| |
|
| |
| | | |
| | | |
| |
|
Michael
R. LaPointe | |
| 15,900 | | |
| 5.56 | | |
12/31/2013 | |
12/30/2023 |
| |
| 7,950 | | |
| 5.19 | | |
12/31/2014 | |
12/30/2024 |
| |
| 7,000 | | |
| 5.26 | | |
12/31/2015 | |
12/30/2025 |
| |
| 5,000 | | |
| 3.11 | | |
12/31/2019 | |
12/30/2029 |
| |
| 5,000 | | |
| 2.875 | | |
12/31/2020 | |
12/30/2030 |
| |
| 5,000 | | |
| 1.72 | | |
12/31/2021 | |
12/30/2031 |
| |
| 6,000 | | |
| 1.95 | | |
12/31/2022 | |
12/20/2032 |
| |
| 51,850 | | |
| | | |
| |
|
Stock
Options Exercised and Stock Vested in 2022
No
stock options were exercised in 2022 by any named executive officer of the Company. No shares of stock were acquired by any named executive
officer in 2022 upon vesting of awards of stock pursuant to the 2019 Plan. There are no unvested awards of restricted stock outstanding
as of the end of 2022 that have been awarded to our named executive officers.
Potential
Payments upon Termination or Change of Control
Mr.
Harary’s employment agreements provide for certain payments and benefits upon a termination, separation, or change in control.
None of our other named executive officers has an employment agreement with us or are otherwise entitled to any sort of cash payment
upon termination or separation from us.
The
2019 Plan, and its predecessor plan (2008 Plan which expired in April 2018), provide for the continuation or acceleration of certain
awards and grants thereunder in the event of specified separations from employment with us. Under the standard grant agreements for options
granted under our 2019 Plan and 2008 Plan, the option holder generally has three months after the date of termination to exercise options
that were exercisable on or before the date that employment ends unless the options’ expiration date occurs first (other than for
death or disability). Upon an option holder’s death or disability, the holder or the holder’s estate, as applicable, may
exercise options that were exercisable on or before the date that employment ends due to death or disability for a period of six months
thereafter, unless the options’ expiration date occurs first. All of the outstanding options issued to our named executive officers
are vested.
Under
award agreements with our named executive officers for restricted stock granted pursuant to our 2008 Plan, each named executive officer’s
unvested restricted stock shall immediately become fully vested as of the date of his termination due to death or disability. In addition,
Mr. Harary’s employment agreement provides that his restricted stock and any additional equity incentive awards granted to him
under the 2019 Plan and the 2008 Plan or otherwise will immediately vest upon his termination by the Company (other than for cause or
in connection with his death or disability), his resignation for good reason or upon change of control of the Company.
Joseph
M. Harary
The
following table describes the potential payments and benefits to Mr. Harary upon termination of his employment or a change of control
of the Company had such termination or change of control occurred on December 31, 2022.
| |
| | |
| | |
By
Company | | |
By
Mr. Harary | | |
| |
Payments
and Benefits | |
Death
($) | | |
Disability
($) | | |
For Cause
($) | | |
Other than for Disability or Cause
($) | | |
For Good Reason
($) | | |
Other than Good Reason
($) | | |
Change of Control
($) | |
| |
| | |
| | |
| | |
| | |
| | |
| | |
| |
Accelerated
vesting of Restricted Stock | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Cash
payment under employment agreement | |
| 250,000 | (1) | |
| 250,000 | (2) | |
| - | | |
| 500,000 | (3) | |
| 500,000 | (3) | |
| - | | |
| 1,500,000 | (3) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Bonus
payable under employment agreement (4) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
|
(1) |
The amount of the benefit shown would be paid over a six-month
period following the date of his death in the manner it would have been paid if Mr. Harary’s employment would have continued. |
|
|
|
|
(2) |
The amount of the benefit shown would be paid in equal installments
over a six-month period following the date of Mr. Harary’s termination on December 31, 2022 at such intervals (at least monthly)
as salaries are paid generally to executive officers of the company. Mr. Harary’s employment agreement provides that the company
shall pay the amount, if any, by which Mr. Harary’s base salary for the period commencing on the date of termination and ending
on the six-month anniversary of such date the exceeds the sum of (i) the amount of base salary received by Mr. Harary with respect to
the period he was disabled and (ii) the sum of the amounts, if any, payable to him under the Company’s benefit plans. The amount
of the benefit shown assumes that Mr. Harary became disabled and was terminated on December 31, 2022, that Mr. Harary did not receive
his base salary during the period in which he was disabled and that no amounts were payable to him under the Company’s benefit
plans. |
|
|
|
|
(3) |
The amount of the benefit shown would be paid over a three-year
period following the date of his termination in the manner it would have been paid if Mr. Harary’s employment had not so terminated. |
|
|
|
|
(4) |
Assumes that Mr. Harary was eligible as of the date of his
termination to receive a bonus in the amount reported in the “Summary Compensation Table” for 2022 and that such bonus payment
had not already been made. |
Michael
R. LaPointe
Mr.
LaPointe is not entitled to any payment upon termination for any other reason or upon a change of control of the Company.
DIRECTOR
COMPENSATION
The
Company believes that it is appropriate to set target levels of director compensation based upon the factors described above for service
on the Company’s Board of Directors. Based in part upon its review of comparable directors fees paid among the Compensation Peer
Group companies, and upon the analysis and recommendations of the independent compensation consulting firm noted above, each non-employee
independent director was to receive total compensation with respect to service as a Director during 2022 having a valuation initially
targeted at approximately $80,000, which targeted amount is then subject to adjustment based upon results achieved and future modification
as a result of prevailing compensation levels and other factors. The mix of cash and equity grant for 2022 was developed following
the review of an independent compensation consulting firm’s report and an evaluation of prevailing trends and best practices in
corporate governance and director compensation in a broad range of public companies.
Non-management
directors of the Company each received compensation for service on the Board in 2022 in an option award granted in December 2022 for
a total of 45,000 shares of Common Stock of the Company (having an estimated value at the time of grant of $58,950 and a cash fee paid
in January 2023 of $40,000. The following table summarizes compensation paid or awarded to the Company’s non-management directors
in 2022. The management director is not compensated separately for their service as a director and their compensation as an employee
of the Company is shown on the “Summary Compensation Table” of this Proxy Statement.
| |
Fees
Paid in | | |
Stock/Option | | |
| |
Name | |
Cash
($) | | |
Awards
($) | | |
Total
($) | |
| |
| | |
| | |
| |
Darryl
Daigle | |
| 40,000 | | |
| 58,950 | | |
| 98,950 | |
Alexander
Kaganowicz | |
| 40,000 | | |
| 58,950 | | |
| 98,950 | |
RELATED-PARTY
TRANSACTIONS
The
Company has no related-party transactions to report for 2022. The Company’s policy is to follow the procedures established under
Delaware corporate law for approval of related-party transactions.
EQUITY
COMPENSATION PLAN INFORMATION
The
following table sets forth information as of December 31, 2022 with respect to shares of the Common Stock that may be issued under the
Company’s existing 2019 Equity Incentive Plan, and any other equity that may be issued to officers or directors of, or consultants
to, the Company. There are no equity compensation plans that were not approved by the Company’s stockholders.
Plan
category | |
Number
of Securities to be issued upon exercise of outstanding options, warrants and rights | | |
Weighted-average
exercise price of outstanding options, warrants and rights | | |
Number
of securities remaining available for future issuance under equity compensation plans | |
| |
| | |
| | |
| |
Equity
compensation plans approved by security holders | |
| 1,400,000 | | |
| 3.35 | | |
| 307,500 | |
| |
| | | |
| | | |
| | |
Equity
compensation plans not approved by security holders | |
| - | | |
| - | | |
| - | |
| |
| | | |
| | | |
| | |
Total | |
| 1,400,000 | | |
$ | 3.35 | | |
| 307,500 | |
STOCK
PRICE PERFORMANCE
The
following table sets forth the range of the high and low selling prices (as provided by the NASDAQ Capital Market) of the Common Stock
for each quarterly period within the past two fiscal years. The following high and low selling prices may reflect inter-dealer prices,
without retail mark-up, mark-down, or commission, and may not necessarily represent actual transactions.
Quarter
Ended | |
Low | | |
High | |
| |
| | |
| |
March
31, 2021 | |
$ | 2.65 | | |
$ | 5.66 | |
June 30, 2021 | |
| 2.01 | | |
| 3.15 | |
September 30, 2021 | |
| 1.76 | | |
| 3.18 | |
December 31, 2021 | |
| 1.65 | | |
| 2.63 | |
| |
| | | |
| | |
March 31, 2022 | |
$ | 1.34 | | |
$ | 2.45 | |
June 30, 2022 | |
| 1.51 | | |
| 2.29 | |
September 30, 2022 | |
| 1.55 | | |
| 2.85 | |
December 31, 2022 | |
| 1.83 | | |
| 2.53 | |
The
following graph compares the total returns (assuming reinvestment of dividends) on $100 invested on December 31, 2017 in the Common Stock
(REFR), the NASDAQ Composite Index and the NASDAQ Electronic Components and Equipment Index. The stock price performance shown on the
graph below reflects historical data and is not necessarily indicative of future price performance.
2024
STOCKHOLDER AND DIRECTOR NOMINATIONS
Any
stockholder who intends to present a proposal for action, including the nomination of a candidate for Director, at the Company’s
2024 Annual Meeting of Stockholders, must comply with and meet the requirements of the Company’s By-Laws and of Rule 14a-8 of the
SEC. Rule 14a-8 requires, among other things, that any proposal be received by the Company at its principal executive office, 240 Crossways
Park Drive, Woodbury, New York 11797, Attention: Corporate Secretary, by December 31, 2023. Section 2.12 of the Company’s By-Laws
(a copy of which is available upon request) sets forth the procedures that must be followed with respect to stockholder nominations,
which include a requirement that the person making the nomination be a stockholder of record at the time of giving notice for such stockholders
meeting and who shall be entitled to vote for the election of directors at the meeting, and that such nomination be made pursuant to
timely notice in proper written form to the Secretary of the Company. To be in proper written form, such notice shall set forth (a) as
to each person whom the stockholder proposes to nominate for election or re-election as a director, (i) the name, age, business address
and residence address of such person, (ii) the principal occupation or employment of such person, (iii) the class and number of shares
of the Company which are owned beneficially and of record by such person, (iv) any other information relating to such person that is
required to be disclosed in solicitations of proxies for election of directors, or is otherwise required, in each case pursuant to Regulation
14A promulgated under the Exchange Act of 1934 (including, without limitation, such person’s written consent to being named in
the Proxy Statement as a nominee and to serving as a director if elected), and (v) any other information that is or would be required
to be disclosed in a Schedule 13D promulgated under the Exchange Act regardless of whether such person would otherwise be required to
file a Schedule 13D, and (b) as to the stockholder giving the notice (i) the name and address, as they appear on the Company’s
books, as such stockholder, (ii) the class and number of shares of the Company which are owned beneficially and of record by such stockholder,
and (iii) a description of all arrangements or understandings between such stockholder and the person nominated by such stockholder,
and any interest by such stockholder in the election of the person nominated by such stockholder, and any relationship between such stockholder
and the person so nominated. In addition, a person providing notice under this Section shall supplementally and promptly provide such
other information as the Company otherwise requests. At the request of the Board, any person nominated by the Board for election as a
director shall furnish to the Secretary of the Company that information required to be set forth in a stockholder’s notice of nomination
which pertains to the nominee.
HOUSEHOLDING
INFORMATION
SEC
regulations permit the Company to send a single set of proxy materials, which includes this Proxy Statement and the Annual Report to
Stockholders, to two or more stockholders that share the same address. Each stockholder will continue to receive his or her own separate
proxy card. Upon written or oral request, the Company will promptly deliver a separate set of proxy materials to a stockholder at a shared
address that only received a single set of proxy materials for this year. If a stockholder would prefer to receive his or her own copy,
please contact Juliette Madden, by telephone at (516) 364-1902, by U.S. mail at Research Frontiers Incorporated, 240 Crossways Park Drive,
Woodbury, NY 11797, or by e-mail at info@SmartGlass.com. Similarly, if a stockholder would like to receive his or her own set of the
Company’s proxy materials in future years or if a stockholder shares an address with another stockholder and both would like to
receive only a single set of the Company’s proxy materials in future years, please contact Juliette Madden.
GENERAL
AND OTHER MATTERS
Management
knows of no matter other than the matters described above which will be presented to the meeting. However, if any other matters properly
come before the meeting, or any of its adjournments, the person or persons voting the proxies will vote them in accordance with his,
her or their best judgment on such matters.
|
By
Order of the Board of Directors |
|
|
|
|
|
JOSEPH
M. HARARY, Secretary |
Woodbury,
New York
April
28, 2023
THE
COMPANY WILL PROVIDE WITHOUT CHARGE A COPY OF THE COMPANY’S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2022 INCLUDING
FINANCIAL STATEMENTS AND ANY SCHEDULES THERETO (EXCEPT EXHIBITS), TO EACH OF THE COMPANY’S STOCKHOLDERS, UPON RECEIPT OF A WRITTEN
REQUEST THEREFOR MAILED TO THE COMPANY’S OFFICES, ATTENTION: SECRETARY. REQUESTS FROM BENEFICIAL STOCKHOLDERS MUST SET FORTH A
REPRESENTATION AS TO SUCH OWNERSHIP ON APRIL 18, 2023.
[PROXY
CARD - FRONT]
PROXY
RESEARCH
FRONTIERS INCORPORATED
240
Crossways Park Drive, Woodbury, New York 11797-2033
THIS
PROXY IS SOLICITED ON BEHALF OF
THE
BOARD OF DIRECTORS
ANNUAL
MEETING OF STOCKHOLDERS - June 8, 2023
The
undersigned hereby appoints Joseph M. Harary and Alexander Kaganowicz, or either of them, as Proxy or Proxies of the undersigned with
full power of substitution to attend and to represent the undersigned at the Annual Meeting of Stockholders of Research Frontiers Incorporated
to be held on June 8, 2023, and at any adjournments thereof, and to vote thereat the number of shares of stock of the Company the undersigned
would be entitled to vote if personally present, in accordance with the instructions set forth on the reverse side hereof. Any proxy
heretofore given by the undersigned with respect to such stock is hereby revoked.
Dated:
___________________________________________, 2023
______________________________________________________
______________________________________________________
Please
sign exactly as name appears above. For joint accounts, each joint owner must sign. Please give full title if signing in a representative
capacity.
PLEASE
MARK, DATE AND SIGN THIS PROXY AND RETURN IT IN THE ENCLOSED ENVELOPE
[PROXY
CARD - BACK]
1. |
ELECTION
OF DIRECTOR
|
|
|
|
CLASS
III NOMINEE: Darryl Daigle |
|
|
|
[ ] FOR
nominees listed above. |
|
|
|
[ ] WITHHOLD
AUTHORITY to vote for nominee listed above. |
|
|
2
. |
RATIFICATION
OF THE SELECTION OF COHNREZNICK LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER
31, 2023. |
|
|
|
[ ] FOR [ ]
AGAINST [ ] ABSTAIN |
|
|
3. |
APPROVE,
BY NON-BINDING VOTE, THE COMPANY’S EXECUTIVE COMPENSATION. |
|
|
|
[ ] FOR [ ]
AGAINST [ ] ABSTAIN |
|
|
4. |
RECOMMEND,
BY NON-BINDING VOTE, THE FREQUENCY OF STOCKHOLDER ADVISORY VOTES ON THE COMPANY’S EXECUTIVE COMPENSATION. |
|
|
|
[ ] 3
YEARS [ ] 2 YEARS [ ]
1 YEAR [ ] ABSTAIN |
|
|
5. |
If
no specification is made, this proxy will be voted FOR the nominee listed above and FOR RATIFICATION of Proposal 2, FOR APPROVAL
of Proposal 3, and 3 YEARS for Proposal 4. |
Please
indicate whether or not you plan to attend the Annual Meeting on Thursday, June 8, 2023.
[ ]
YES [ ] NO
Grafico Azioni Research Frontiers (NASDAQ:REFR)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Research Frontiers (NASDAQ:REFR)
Storico
Da Nov 2023 a Nov 2024